CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Quality of life (QOL) in a phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 (NCT00820248).
Author
Abdenour Nabid
Alex Hammond
+18Â more
Alexander Montenegro
Ali Abdel Halim El-Gayed
Bingshu E. Chen
Brian O'Sullivan
Carson Leong
Eric Winquist
Farah Naz
Jim R. Wright
John H Hay
John N. Waldron
Jolie Ringash
Kevin Ramchandar
Khalil Sultanem
Lillian L. Siu
Rosemary Martino
Sebastien Hotte
Tim E Owen
Wendy R. Parulekar
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref